Canton Strategic (CNTN) vs NovaBridge Biosciences (NBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Canton Strategic (CNTN) has outperformed NovaBridge Biosciences (NBP) over the past year, losing 34.6% versus a loss of 73.0%. Canton Strategic is the larger company by market cap ($168.1 million vs $161.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | NBP |
|---|---|---|
| Share price | $2.11 | $1.40 |
| Market cap | $168.13M | $161.82M |
| 1-day change | +1.44% | +1.82% |
| YTD return | -31.35% | -65.58% |
| 1-year return | -34.59% | -72.98% |
| 5-year return | — | -97.92% |
| EPS (TTM) | $-0.10 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.89 | $6.79 |
| 52-week low | $1.75 | $1.31 |
| Distance from 52-week high | -69.38% | -79.46% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +545.16% |
| Average volume | 758.86K | 382.99K |
| Shares outstanding | 79.68M | 116.00M |
| Employees | 12 | 30 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNTN has outperformed NBP by 38.4 percentage points over the past year.
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About NovaBridge Biosciences
NBP stock →NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology.
Health Care · Biotechnology: Pharmaceutical Preparations · 30 employees
CNTN vs NBP FAQ
Which is bigger, Canton Strategic or NovaBridge Biosciences?
Canton Strategic (CNTN) is larger, with a market capitalization of $168.13M compared with $161.82M for NovaBridge Biosciences (NBP).
Which stock has performed better over the past year, CNTN or NBP?
CNTN returned -34.59% over the past 12 months, compared with -72.98% for NBP (price return, excluding dividends). Past performance does not predict future results.
Are Canton Strategic and NovaBridge Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.